These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 24727284)

  • 1. Breast cancer stem cells: Multiple capacities in tumor metastasis.
    Geng SQ; Alexandrou AT; Li JJ
    Cancer Lett; 2014 Jul; 349(1):1-7. PubMed ID: 24727284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SURVIVIN as a marker for quiescent-breast cancer stem cells-An intermediate, adherent, pre-requisite phase of breast cancer metastasis.
    Siddharth S; Das S; Nayak A; Kundu CN
    Clin Exp Metastasis; 2016 Oct; 33(7):661-75. PubMed ID: 27411340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RUNX1 and RUNX2 transcription factors function in opposing roles to regulate breast cancer stem cells.
    Fritz AJ; Hong D; Boyd J; Kost J; Finstaad KH; Fitzgerald MP; Hanna S; Abuarqoub AH; Malik M; Bushweller J; Tye C; Ghule P; Gordon J; Frietze S; Zaidi SK; Lian JB; Stein JL; Stein GS
    J Cell Physiol; 2020 Oct; 235(10):7261-7272. PubMed ID: 32180230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microRNAs in the regulation of breast cancer stem cells.
    Liu S; Clouthier SG; Wicha MS
    J Mammary Gland Biol Neoplasia; 2012 Mar; 17(1):15-21. PubMed ID: 22331423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer stem cell: the roles and therapeutic implications.
    Yang F; Xu J; Tang L; Guan X
    Cell Mol Life Sci; 2017 Mar; 74(6):951-966. PubMed ID: 27530548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity and Plasticity of Breast Cancer Stem Cells.
    Sousa B; Ribeiro AS; Paredes J
    Adv Exp Med Biol; 2019; 1139():83-103. PubMed ID: 31134496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cell-targeted therapeutic approaches for overcoming trastuzumab resistance in HER2-positive breast cancer.
    Qiu Y; Yang L; Liu H; Luo X
    Stem Cells; 2021 Sep; 39(9):1125-1136. PubMed ID: 33837587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrodynamic shear stress promotes epithelial-mesenchymal transition by downregulating ERK and GSK3β activities.
    Choi HY; Yang GM; Dayem AA; Saha SK; Kim K; Yoo Y; Hong K; Kim JH; Yee C; Lee KM; Cho SG
    Breast Cancer Res; 2019 Jan; 21(1):6. PubMed ID: 30651129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy.
    Pham PV; Phan NL; Nguyen NT; Truong NH; Duong TT; Le DV; Truong KD; Phan NK
    J Transl Med; 2011 Dec; 9():209. PubMed ID: 22152097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells in solid and liquid tissues of breast cancer patients: characterization and therapeutic perspectives.
    Chiotaki R; Polioudaki H; Theodoropoulos PA
    Curr Cancer Drug Targets; 2015; 15(3):256-69. PubMed ID: 25669721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of resistance to chemotherapy and ionizing radiation in breast cancer stem cells.
    Pavlopoulou A; Oktay Y; Vougas K; Louka M; Vorgias CE; Georgakilas AG
    Cancer Lett; 2016 Oct; 380(2):485-493. PubMed ID: 27450721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer.
    Sun L; Burnett J; Gasparyan M; Xu F; Jiang H; Lin CC; Myers I; Korkaya H; Liu Y; Connarn J; He H; Zhang N; Wicha MS; Sun D
    Oncotarget; 2016 Aug; 7(32):51408-51422. PubMed ID: 27285982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer stem cells: current advances and clinical implications.
    Luo M; Clouthier SG; Deol Y; Liu S; Nagrath S; Azizi E; Wicha MS
    Methods Mol Biol; 2015; 1293():1-49. PubMed ID: 26040679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer.
    Wang C; Xu K; Wang R; Han X; Tang J; Guan X
    J Exp Clin Cancer Res; 2021 Nov; 40(1):370. PubMed ID: 34801088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).
    Martin-Castillo B; Oliveras-Ferraros C; Vazquez-Martin A; Cufí S; Moreno JM; Corominas-Faja B; Urruticoechea A; Martín ÁG; López-Bonet E; Menendez JA
    Cell Cycle; 2013 Jan; 12(2):225-45. PubMed ID: 23255137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition and stem cell markers in patients with HER2-positive metastatic breast cancer.
    Giordano A; Gao H; Anfossi S; Cohen E; Mego M; Lee BN; Tin S; De Laurentiis M; Parker CA; Alvarez RH; Valero V; Ueno NT; De Placido S; Mani SA; Esteva FJ; Cristofanilli M; Reuben JM
    Mol Cancer Ther; 2012 Nov; 11(11):2526-34. PubMed ID: 22973057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling pathways governing breast cancer stem cells behavior.
    Song K; Farzaneh M
    Stem Cell Res Ther; 2021 Apr; 12(1):245. PubMed ID: 33863385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Breast Cancer Stem Cells.
    Zhang L; Chen W; Liu S; Chen C
    Int J Biol Sci; 2023; 19(2):552-570. PubMed ID: 36632469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.